Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Russell 2000 Stocks We Steer Clear Of

By: StockStory

July 16, 2026 at 00:35 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

TXG Cover Image

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Navigating this part of the market can be tricky, which is why we built StockStory to help you separate the winners from the laggards. That said, here are three Russell 2000 stocks to avoid and better alternatives to consider.

10x Genomics (TXG)

Market Cap: $5.81 billion

Founded in 2012 by scientists seeking to overcome limitations in traditional biological research methods, 10x Genomics (NASDAQ: TXG) develops instruments, consumables, and software that enable researchers to analyze biological systems at single-cell resolution and spatial context.

Why Are We Out on TXG?

Sales trends were unexciting over the last two years as its 1.1% annual growth was below the typical healthcare company
Subscale operations are evident in its revenue base of $638.8 million, meaning it has fewer distribution channels than its larger rivals
Negative returns on capital show that some of its growth strategies have backfired

At $45.86 per share, 10x Genomics trades at 9.4x forward price-to-sales. Check out our free in-depth research report to learn more about why TXG doesn’t pass our bar.

Employers Holdings (EIG)

Market Cap: $887.5 million

With roots in Nevada and a strong concentration in California where 45% of its premiums are generated, Employers Holdings (NYSE: EIG) is a specialty provider of workers' compensation insurance focused on small and select businesses engaged in low-to-medium hazard industries across the United States.

Why Should You Dump EIG?

Sluggish 1.7% annualized growth in net premiums earned over the last two years indicates the firm trailed its insurance peers
Expenses have increased as a percentage of revenue over the last five years as its pre-tax profit margin fell by 28.5 percentage points
Earnings per share fell by 29.6% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable

Employers Holdings’s stock price of $48.67 implies a valuation ratio of 1x forward P/B. To fully understand why you should be careful with EIG, check out our full research report (it’s free).

S&T Bancorp (STBA)

Market Cap: $1.77 billion

Tracing its roots back to 1902 in western Pennsylvania's industrial heartland, S&T Bancorp (NASDAQ: STBA) is a Pennsylvania-based bank holding company that provides retail and commercial banking services, cash management, trust services, and investment advisory solutions.

Why Are We Hesitant About STBA?

Muted 4.9% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
Anticipated net interest income growth of 4.1% for the next year implies demand will be shaky
Earnings per share were flat over the last two years and fell short of the peer group average

S&T Bancorp is trading at $49.32 per share, or 1.2x forward P/B. Dive into our free research report to see why there are better opportunities than STBA.

Stocks We Like More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	268.08	+32.58 (13.83%)
AAPL	300.80	-32.63 (-9.79%)
AMD	489.22	+3.83 (0.79%)
BAC	62.09	+0.37 (0.59%)
GOOG	350.07	+16.39 (4.91%)
META	546.56	+7.53 (1.40%)
MSFT	460.85	+9.75 (2.16%)
NVDA	196.02	+0.98 (0.50%)
ORCL	126.66	-0.90 (-0.71%)
TSLA	307.13	-1.72 (-0.56%)